These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 10235608
1. Bowman-Birk inhibitor concentrate reduces colon inflammation in mice with dextran sulfate sodium-induced ulcerative colitis. Ware JH, Wan XS, Newberne P, Kennedy AR. Dig Dis Sci; 1999 May; 44(5):986-90. PubMed ID: 10235608 [Abstract] [Full Text] [Related]
2. Bowman-Birk inhibitor concentrate: a novel therapeutic agent for patients with active ulcerative colitis. Lichtenstein GR, Deren JJ, Katz S, Lewis JD, Kennedy AR, Ware JH. Dig Dis Sci; 2008 Jan; 53(1):175-80. PubMed ID: 17551835 [Abstract] [Full Text] [Related]
3. Bowman-Birk inhibitor concentrate prevents atrophy, weakness, and oxidative stress in soleus muscle of hindlimb-unloaded mice. Arbogast S, Smith J, Matuszczak Y, Hardin BJ, Moylan JS, Smith JD, Ware J, Kennedy AR, Reid MB. J Appl Physiol (1985); 2007 Mar; 102(3):956-64. PubMed ID: 17110517 [Abstract] [Full Text] [Related]
4. The protease inhibitor, Bowman-Birk Inhibitor, suppresses experimental autoimmune encephalomyelitis: a potential oral therapy for multiple sclerosis. Gran B, Tabibzadeh N, Martin A, Ventura ES, Ware JH, Zhang GX, Parr JL, Kennedy AR, Rostami AM. Mult Scler; 2006 Dec; 12(6):688-97. PubMed ID: 17262995 [Abstract] [Full Text] [Related]
5. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent. Kennedy AR. Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1406S-1412S. PubMed ID: 9848508 [Abstract] [Full Text] [Related]
6. Development of the Bowman-Birk inhibitor for oral cancer chemoprevention and analysis of Neu immunohistochemical staining intensity with Bowman-Birk inhibitor concentrate treatment. Armstrong WB, Wan XS, Kennedy AR, Taylor TH, Meyskens FL. Laryngoscope; 2003 Oct; 113(10):1687-702. PubMed ID: 14520092 [Abstract] [Full Text] [Related]
7. Development of tobacco smoke-induced lung tumors in mice fed Bowman-Birk protease inhibitor concentrate (BBIC). Witschi H, Espiritu I. Cancer Lett; 2002 Sep 26; 183(2):141-6. PubMed ID: 12065088 [Abstract] [Full Text] [Related]
8. Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress x-ray-induced transformation in vitro. Yavelow J, Collins M, Birk Y, Troll W, Kennedy AR. Proc Natl Acad Sci U S A; 1985 Aug 26; 82(16):5395-9. PubMed ID: 3860869 [Abstract] [Full Text] [Related]
9. Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial. Armstrong WB, Kennedy AR, Wan XS, Taylor TH, Nguyen QA, Jensen J, Thompson W, Lagerberg W, Meyskens FL. Clin Cancer Res; 2000 Dec 26; 6(12):4684-91. PubMed ID: 11156220 [Abstract] [Full Text] [Related]
10. Protection against metastasis of radiation-induced thymic lymphosarcoma and weight loss in C57Bl/6NCr1BR mice by an autoclave-resistant factor present in soybeans. Evans SM, Van Winkle T, Szuhaj B, Michel KE, Kennedy AR. Radiat Res; 1992 Nov 26; 132(2):259-62. PubMed ID: 1438709 [Abstract] [Full Text] [Related]
11. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate. Wan XS, Serota DG, Ware JH, Crowell JA, Kennedy AR. Nutr Cancer; 2002 Nov 26; 43(2):167-73. PubMed ID: 12588697 [Abstract] [Full Text] [Related]
12. Preparation and production of a cancer chemopreventive agent, Bowman-Birk inhibitor concentrate. Kennedy AR, Szuhaj BF, Newberne PM, Billings PC. Nutr Cancer; 1993 Nov 26; 19(3):281-302. PubMed ID: 8346077 [Abstract] [Full Text] [Related]
13. Suppression of carcinogenesis in the intestines of min mice by the soybean-derived Bowman-Birk inhibitor. Kennedy AR, Beazer-Barclay Y, Kinzler KW, Newberne PM. Cancer Res; 1996 Feb 15; 56(4):679-82. PubMed ID: 8630994 [Abstract] [Full Text] [Related]
14. Bowman-Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis. Touil T, Ciric B, Ventura E, Shindler KS, Gran B, Rostami A. J Neurol Sci; 2008 Aug 15; 271(1-2):191-202. PubMed ID: 18544456 [Abstract] [Full Text] [Related]
15. Bowman-Birk inhibitor suppresses production of superoxide anion radicals in differentiated HL-60 cells. Ware JH, Wan XS, Kennedy AR. Nutr Cancer; 1999 Aug 15; 33(2):174-7. PubMed ID: 10368813 [Abstract] [Full Text] [Related]
16. Effects of the Bowman-Birk inhibitor on clonogenic survival and cisplatin- or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells. Zhang L, Wan XS, Donahue JJ, Ware JH, Kennedy AR. Nutr Cancer; 1999 Aug 15; 33(2):165-73. PubMed ID: 10368812 [Abstract] [Full Text] [Related]
17. Modulation of lung tumor development in mice with the soybean-derived Bowman-Birk protease inhibitor. Witschi H, Kennedy AR. Carcinogenesis; 1989 Dec 15; 10(12):2275-7. PubMed ID: 2591017 [Abstract] [Full Text] [Related]
18. Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia. Malkowicz SB, McKenna WG, Vaughn DJ, Wan XS, Propert KJ, Rockwell K, Marks SH, Wein AJ, Kennedy AR. Prostate; 2001 Jun 15; 48(1):16-28. PubMed ID: 11391683 [Abstract] [Full Text] [Related]
19. Effect of the Bowman-Birk inhibitor (a soy protein) on in vitro bladder neck/urethral and penile corporal smooth muscle activity. Malkowicz SB, Liu SP, Broderick GA, Wein AJ, Kennedy AR, Levin RM. Neurourol Urodyn; 2003 Jun 15; 22(1):54-7. PubMed ID: 12478602 [Abstract] [Full Text] [Related]
20. Soybean Bowman-Birk protease inhibitor (BBI): identification of the mechanisms of BBI suppressive effect on growth of two adenocarcinoma cell lines: AGS and HT29. Fereidunian A, Sadeghalvad M, Oscoie MO, Mostafaie A. Arch Med Res; 2014 Aug 15; 45(6):455-61. PubMed ID: 25014623 [Abstract] [Full Text] [Related] Page: [Next] [New Search]